DXCM Financial Facts

Selling, general and administrative: 39.4M
Research and development: 19.8M
See Full Income Statement

Accumulated deficit: -510.7M
Total liabilities and stockholders' equity: 189.3M
See Full Balance Sheet

DexCom, Inc. (DXCM) Earnings

  |   Expand Research on DXCM
Next EPS Date 8/6/15 *Est. EPS Growth Rate 0.0% *Last Qtr.
Average EPS % Beat Rate +28.9% Revenue Growth Rate +55.9% *Last Qtr.
Average % Move 1-Wk after EPS +8.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/29/15 Q115 -$0.17-$0.11 -$0.06$72.8M$71.32M N/A Details
2/25/15 Q414 $0.02-$0.03 +$0.05$84.3M$79.65M N/A Details
11/6/14 Q314 -$0.07-$0.06 -$0.01$69M$60.2M N/A Details
8/6/14 Q214 -$0.08-$0.10 +$0.02$58.8M$52.45M N/A Details
5/1/14 Q114 -$0.17-$0.08 -$0.09$46.7M$44.15M N/A Details
2/20/14 Q413 -$0.04-$0.07 +$0.03$51.3M$48.53M N/A Details
11/6/13 Q313 -$0.09-$0.13 +$0.04$42.9M$35.9M N/A Details
8/7/13 Q213 -$0.14-$0.16 +$0.02$35.5M$31.14M N/A Details